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CHARACTERISTICS OF HEREDITARY OVARIAN CANCER
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Department of Cancer Prevention and Epidemiology at the Wielkopolska Oncological Center
Ovarian cancer is the fifth major cause
of cancer-related mortality among women. In
Wielkopolska, higher incidence and mortality
rates are observed compared to other regions of
Poland. Ovarian cancer affects mainly women in
their sixties and seventies. The etiology of this
disease has not been fully understood yet. The
factors contributing to increased risk of ovarian
cancer occurrence include infertility, breast
cancer diagnosed before the age of 45 and
family history of ovarian cancer while
childbearing and oral contraceptives are
considered to be protective factors.
Simultaneous genetic and
epidemiological studies based on analyzing
pedigrees of families with multiple cases of
ovarian cancer and indicate a role of the genetic
factor in ovarian cancer etiology. Familial forms
of ovarian cancer which represent
approximately 5-10% of all cases are associated
with certain syndromes, including: familial breast
and ovarian cancer syndrome related to
mutations in BRCA1, familial breast cancer
syndrome related to' mutations in BRCA2 which
can be accompanied by ovarian cancer, Lynch \I
syndrome characterized by the occurrence of
ovarian cancer, colon cancer and endometrial
cancer in the family as well as the syndrome of
hereditary non-polypous colon cancer (HNPCC).
Genetic ovarian cancer is most often diagnosed
before the age of fifty.
Identification of individuals with a high
risk of genetic predisposition to developing
ovarian cancer should be based on precise
information collected during interviews with
family members complemented by the data on
personal risk factors. Women identified as
members of high-risk groups can be offered
genetic testing aimed at detecting asymptomatic
carriers of mutations in genes predisposing to
ovarian cancer.
On the one hand, genetic tests
represent a new, extremely powerful instrument
for identifying individuals genetically
predisposed to ovarian cancer, on the other
hand, however, they create numerous problems.
The two basic controversies which need
clarifying are: who should be offered genetic
testing and what preventive measures can be
taken to help women carrying gene mutations
increasing the risk of developing cancer,
including ovarian cancer. Most issues related to
genetic types of cancer (including ovarian)
require further investigation and studies and
currently proposed protocols are still widely
discussed.
CONTROVERSY OVER RADIOTHERAPY IN 1 STAGE SEMINOMAS
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In the past years efforts have been made
to find the least eradicating methods of
complementary therapy in the treatment of 1 st
stage seminomas.
In the Polish centers, as in the majority of centers
of the world, complementary irradiation of the
lymphatic system is applied. The efficiency of this
procedure (almost 100% of cured cases) causes
that few centers decide to change the treatment.
Objective: comparison of the treatment of 1 st
stage seminomas preceded by orchidectomy
a) selective irradiation
b) withdrawal from irradation - observation.
59
Group A - 75 patients treated between 1977 and
1986 were irradiated.
Group B - 31 patients treated between 1987 and
1991 were under constant observation.
The percentage of cases with a 5-year
survival is convergent and independent of the
applied method. Considering the fact that mainly
young men are affected (18 - 35 years) treatment
should be optimized during the most active part of
their lives; after performing orchidectomy and
detailed examinations (histopathology, CT,
ultrasonography, markers) that is after eXcluding
high risk factors - the patients should remain
under observation.!!
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